Article

Journal of Cancer Education

, Volume 25, Issue 4, pp 493-496

First online:

A Teaching Model for Aromatase Inhibitors After Tamoxifen

  • Theresa TrotterAffiliated withDepartment of Radiation Oncology, Faculty of Medicine, University of CalgaryTom Baker Cancer Center Email author 
  • , Marc WebsterAffiliated withDepartment of Medical Oncology, Faculty of Medicine, University of Calgary
  • , Cindy RailtonAffiliated withDepartment of Medical Oncology, Faculty of Medicine, University of Calgary
  • , A. H. G. PatersonAffiliated withDepartment of Medical Oncology, Faculty of Medicine, University of Calgary
  • , Tyrone DonnonAffiliated withDepartment of Community Health Sciences, Faculty of Medicine, University of Calgary

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Breast cancer is the most common cancer diagnosed in women. The present study evaluated the family physicians' (FPs) understanding of adjuvant hormonal therapies for an early breast cancer. FPs were invited to attend teaching workshops on this topic, which utilized a pretest, didactic and interactive teaching, and posttest format. FPs (n = 23) showed an improvement (p < 0.001) in pretest to posttest score. It is clear that, with a targeted teaching, FPs can quickly become more knowledgeable on the topic of hormonal therapies in breast cancer, with the potential of applying this information in their own practice.

Keywords

Tamoxifen Physician Aromatase inhibitors Teaching model Letrozole